1,441 results match your criteria Archives Of Cardiovascular Diseases[Journal]


Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.

Arch Cardiovasc Dis 2022 Apr 27. Epub 2022 Apr 27.

AP-HP, Sorbonne University, 75013 Paris, France. Electronic address:

Background: Immune-checkpoint inhibitor-associated myocarditis (ICI-myocarditis) often presents with arrhythmias, but the prognostic value of early electrocardiogram findings is unclear. Although ICI-myocarditis and acute cellular rejection (ACR) following cardiac transplantation use similar treatment strategies, differences in arrhythmia burden are unknown.

Objective: To evaluate the association of electrocardiogram findings in ICI-myocarditis with myocarditis-related mortality and life-threatening arrhythmia. Read More

View Article and Full-Text PDF

Definition and diagnosis of paradoxical aortic stenosis: A call for reappraisal.

Arch Cardiovasc Dis 2022 Apr 21. Epub 2022 Apr 21.

Pôle Cœur-Thorax-Vaisseaux, Department of Cardiology, University Hospital Amiens, 80054 Amiens, France; EA 7517 MP3CV, Jules-Verne University of Picardie, 80054 Amiens, France.

View Article and Full-Text PDF

Does the influenza A vaccine have a direct atheroprotective effect?

Arch Cardiovasc Dis 2022 Apr 21. Epub 2022 Apr 21.

EA4245 T2i, Tours University, 37032 Tours, France; Cardiology Unit, Trousseau Hospital, Tours University Hospital, 37044 Tours, France.

View Article and Full-Text PDF

Transcatheter aortic valve implantation: The road to a minimalist "stent-like" procedure.

Arch Cardiovasc Dis 2022 Apr 29;115(4):196-205. Epub 2022 Apr 29.

Department of Cardiology, CHU Rouen, U1096, Normandie University, UNIROUEN, 76000 Rouen, France. Electronic address:

Background: Since the first-in-man implantation of a transcatheter aortic stented valve in April 2002 in Rouen, the procedure has expanded worldwide. In our centre, all transfemoral procedures have been performed using local anaesthesia without transoesophageal echocardiographic monitoring.

Aim: To report our experience of transfemoral arterial transcatheter aortic valve implantation (TAVI) over the last 2 decades, following the evolution of devices, practices and indications. Read More

View Article and Full-Text PDF

Looking back to the early phase of TAVI development: The long journey from concept to clinical application.

Authors:
Alain Cribier

Arch Cardiovasc Dis 2022 04 27;115(4):193-195. Epub 2022 Apr 27.

Department of Cardiology, CHU de Rouen, 76000 Rouen, France; Department of Cardiology, Normandie Univ, UNIROUEN, U1096, CHU de Rouen, 76000 Rouen, France. Electronic address:

View Article and Full-Text PDF

Long-term outcomes of new-onset conduction abnormalities following transcatheter aortic valve implantation.

Arch Cardiovasc Dis 2022 Apr 22;115(4):214-224. Epub 2022 Apr 22.

Department of Cardiology, Inselspital, University of Bern, 3010 Bern, Switzerland. Electronic address:

Background: Previous studies provided conflicting data on the impact of new conduction abnormalities (CA), including new left bundle branch block (LBBB) and permanent pacemaker (PPM) implantation, on patient outcomes after transcatheter aortic valve implantation (TAVI).

Aims: To investigate the effect of new-onset CA after TAVI on long-term clinical outcomes and the impact of new CA depending on patient baseline profile.

Methods: Using data from a prospective TAVI registry (NCT01368250), patients without pre-existing LBBB or PPM were included in this study, and were stratified into three groups: no CA, new LBBB and new PPM after TAVI. Read More

View Article and Full-Text PDF

Hypertension management: Back to the future.

Arch Cardiovasc Dis 2022 Apr 21. Epub 2022 Apr 21.

Fédération de cardiologie, hôpital de la Croix-Rousse et Hôpital Lyon Sud, Hospices Civils de Lyon, 69004 Lyon, France; Université de Lyon, CREATIS, CNRS UMR 5220, Inserm U1044, INSA-Lyon, Université Claude-Bernard Lyon 1, 69621 Villeurbanne, France.

View Article and Full-Text PDF

TAVI: From concept to success. The story from a surgeon's point of view. Thoughts from three generations.

Arch Cardiovasc Dis 2022 04 22;115(4):231-234. Epub 2022 Apr 22.

Baylor Scott & White Health, 75246 Dallas, TX, USA.

View Article and Full-Text PDF

The 20-year "imaging saga" for transcatheter aortic valve implantation: A viewpoint.

Arch Cardiovasc Dis 2022 04 26;115(4):225-230. Epub 2022 Apr 26.

Department of Cardiology, National University of Ireland, Galway H91 YR71, Ireland; National Heart and Lung Institute, Imperial College London,, London SW3 6LY, UK.

View Article and Full-Text PDF

How to use the aortic valve calcium score to improve the results of transcatheter aortic valve implantation with a self-expanding prosthesis.

Arch Cardiovasc Dis 2022 Apr 21. Epub 2022 Apr 21.

Service de Cardiologie, CHU Clermont-Ferrand, Université Clermont Auvergne, CNRS, SIGMA Clermont, Institut Pascal, 63000 Clermont-Ferrand, France.

Background: In recent years, transcatheter aortic valve implantation (TAVI) without predilation (direct TAVI) has become the preferred method for implanting TAVI prostheses. Appropriate patient selection is important to avoid suboptimal outcomes and associated complications.

Aim: To evaluate whether aortic valve calcification measured with computed tomography predicts suboptimal results from direct TAVI with a self-expanding prosthesis. Read More

View Article and Full-Text PDF

Evolution of TAVI patients and techniques over the past decade: The French TAVI registries.

Arch Cardiovasc Dis 2022 Apr 27;115(4):206-213. Epub 2022 Apr 27.

University Hospital of Brest, 29200 Brest, France. Electronic address:

Background: The French transcatheter aortic valve implantation (TAVI) registries, linked with the nationwide administrative databases, have collected data on TAVI procedures from the first experience to current practices.

Objective: To investigate changes over the past decade in patient and procedural characteristics, major complications and mortality after TAVI.

Methods: Data from the France TAVI and FRANCE 2 registries, collected between 2010 and 2021, were linked using a probabilistic algorithm to the French national health single-payer claims database (SNDS). Read More

View Article and Full-Text PDF

TAVI in 2022: Remaining issues and future direction.

Arch Cardiovasc Dis 2022 Apr 20;115(4):235-242. Epub 2022 Apr 20.

Centres for Heart Valve Innovation and for Cardiovascular Innovation, St. Paul's and Vancouver General Hospital, Vancouver BC V6E 1M7, Canada; Division of Cardiology, University of British Columbia & St. Paul's Hospital, Vancouver, BC V6E 1M7, Canada; Cardiovascular Translational Laboratory, Centre for Heart Lung Innovation, University of British Columbia & St. Paul's Hospital, Vancouver, BC V6E 1M7, Canada. Electronic address:

Since the first-in-human procedure in 2002, transcatheter aortic valve implantation (TAVI) has become a well-established therapeutic option for severe aortic stenosis, and is offered increasingly to patients at lower surgical risk, who are typically younger. Increasing lifespan carries concerns that "minor" complications that may have little impact in elderly patients could have a greater long-term impact in younger patients. Issues such as mild paravalvular regurgitation, hypoattenuated leaflet thickening, atrioventricular block with need for permanent pacemaker implantation or future coronary access may have a substantial cumulative undesirable impact. Read More

View Article and Full-Text PDF

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Evaluation of haemodynamic effects, complication rates and radiation exposure over time.

Arch Cardiovasc Dis 2022 Apr 21. Epub 2022 Apr 21.

Service de Cardiologie, Pôle Thorax et Vaisseaux, Centre Hospitalier Universitaire Grenoble Alpes, 38043 Grenoble, France.

Background: In patients undergoing balloon pulmonary angioplasty (BPA) for inoperable chronic thromboembolic pulmonary hypertension (CTEPH), single-centre series from expert centres have recognized a learning curve for the magnitude of haemodynamic benefits.

Objective: To report our 7-year experience with BPA, focusing on haemodynamic effects, complication rates and radiation exposure over time.

Methods: Patients with CTEPH who were treated with BPA between May 2013 and February 2020 were analysed during the 'initial period' versus the 'recent period' (split date: March 2017). Read More

View Article and Full-Text PDF

Prospective evolution of cardiac arrhythmia care: 2030 vision.

Arch Cardiovasc Dis 2022 Mar 8;115(3):179-189. Epub 2022 Mar 8.

Hôpital Européen Georges-Pompidou, Paris Cardiovascular Research Centre, INSERM U970, 75015 Paris, France.

Cardiovascular diseases, which are the leading global cause of death, should increase by 40% by 2030, reaching close to 24 million deaths worldwide. Atrial fibrillation is the most common heart rhythm disorder, ahead of conduction disturbances and ventricular arrhythmias. Studies estimate that 7. Read More

View Article and Full-Text PDF

Epinephrine use and initial non-shockable rhythm: Tools for predicting death and poor neurological outcome after an out-of-hospital cardiac arrest with a return of spontaneous circulation.

Arch Cardiovasc Dis 2022 Mar 22. Epub 2022 Mar 22.

Emergency Department, Toulouse University Hospital, 31059 Toulouse, France; CERPOP, Toulouse University, Inserm, UPS, Toulouse, France. Electronic address:

View Article and Full-Text PDF

Why should we move from classification to characterization of atrial fibrillation?

Authors:
Olivier Piot

Arch Cardiovasc Dis 2022 03 4;115(3):122-125. Epub 2022 Mar 4.

Département de Rythmologie, Centre Cardiologique du Nord, 93200 Saint-Denis, France. Electronic address:

View Article and Full-Text PDF

Coronary artery calcifications and 6-month mortality in patients with COVID-19 without known atheromatous disease.

Arch Cardiovasc Dis 2022 Mar 4. Epub 2022 Mar 4.

Faculté de médecine, université de Paris, 75006 Paris, France; Institut national de la santé et de la recherche médicale, PARCC, UMR970, 75015 Paris, France; Department of cardiology, hôpital européen Georges-Pompidou, AP-HP, 75015 Paris, France. Electronic address:

Background: Coronary artery calcium (CAC) is an independent risk factor for major adverse cardiovascular events; however, its impact on coronavirus disease 2019 (COVID-19) mortality remains unclear, especially in patients without known atheromatous disease.

Aims: To evaluate the association between CAC visual score and 6-month mortality in patients without history of atheromatous disease hospitalized with COVID-19 pneumonia.

Methods: A single-centre observational cohort study was conducted, involving 293 consecutive patients with COVID-19 in Paris, France, between 13 March and 30 April 2020, with a 6-month follow-up. Read More

View Article and Full-Text PDF

Deleterious synergistic effects of acute heart failure and diabetes mellitus in patients with acute coronary syndrome: Data from the FAST-MI Registries.

Arch Cardiovasc Dis 2022 Mar 4. Epub 2022 Mar 4.

Department of Cardiology, INSERM U-970, European Hospital of Georges-Pompidou, Assistance publique-Hôpitaux de Paris, Université de Paris, 75015 Paris, France. Electronic address:

Background: Diabetes mellitus (DM) predisposes patients to acute myocardial infarction (AMI) and acute heart failure (AHF).

Aims: To assess correlates of AHF occurring at the early stage of AMI and synergism between early AHF and DM on 5-year mortality.

Methods: FAST-MI 2005 and 2010 included 7839 consecutive patients admitted for AMI. Read More

View Article and Full-Text PDF

Multifactorial pulmonary hypertension in infantile scimitar syndrome.

Arch Cardiovasc Dis 2022 Mar 4;115(3):142-150. Epub 2022 Mar 4.

M3C-Necker, Hôpital Necker-Enfants Malades, AP-HP, Université de Paris, Cardiologie Congénitale et Pédiatrique, 149, rue de Sèvres, 75015 Paris, France.

Background: Pulmonary hypertension in infantile scimitar syndrome is highly prevalent at diagnosis, and has a multifactorial origin.

Aims: To analyse the constellation of anatomical anomalies and initial physiology, and their contribution to pulmonary hypertension and outcome in infantile scimitar syndrome.

Methods: Pulmonary hypertension causes were classified into five categories: associated with systemic supply to the right lung; associated with left-to-right shunt; postcapillary; related to respiratory or developmental lung disease; and "idiopathic-like" pulmonary arterial hypertension. Read More

View Article and Full-Text PDF

Linear lesions for treating the recurrence of persistent atrial tachyarrhythmia after cryoballoon ablation of atrial fibrillation.

Arch Cardiovasc Dis 2022 Mar 4. Epub 2022 Mar 4.

Clinique de l'Europe.

Background: There is no consensus on the most effective radiofrequency ablation strategy for the initial or repeated treatment of persistent atrial tachyarrhythmia (ATa).

Objective: To describe success and complication rates after the creation of left atrial (LA) linear lesions for recurrent persistent ATa following an index cryoballoon pulmonary vein isolation (PVI), and to identify predictors of ATa recurrence.

Methods: During March 2013 to March 2020, we prospectively included all consecutive patients undergoing repeat procedures for the treatment of persistent ATa. Read More

View Article and Full-Text PDF

Right heart catheterization in advanced systolic heart failure. What are the most useful haemodynamic parameters for risk stratification?

Arch Cardiovasc Dis 2022 Mar 4;115(3):169-178. Epub 2022 Mar 4.

CHU Lille, Service de cardiologie, 59000 Lille, France; Inserm U1167, Institut Pasteur de Lille, 59000 Lille, France; Faculté de médecine de Lille, Université de Lille 2, Lille, France.

Background: Previous studies have shown that pulmonary hypertension is a predictor of mortality in patients with systolic heart failure (SHF). Persistent pulmonary hypertension after a reactivity test is associated with a worse outcome after transplantation. Recent studies have shown the utility of different haemodynamic parameters. Read More

View Article and Full-Text PDF

Tricuspid regurgitation: Light at the end of the tunnel?

Arch Cardiovasc Dis 2022 03 4;115(3):117-121. Epub 2022 Mar 4.

Department of Cardiology, University of Ottawa Heart Institute, Ottawa, ON K1Y 4W7, Canada.

View Article and Full-Text PDF

Radiation dose during catheter ablation in children using a low fluoroscopy frame rate.

Arch Cardiovasc Dis 2022 Mar 22;115(3):151-159. Epub 2022 Feb 22.

Department of cardiology, university hospital Rangueil, Toulouse, France; I2MC, Inserm UMR 1297, Toulouse, France. Electronic address:

Background: Catheter ablation (CA) in children using fluoroscopy carries risks inherent to ionizing radiation exposure.

Aims: The objective of this study was to demonstrate the feasibility of using low frames rate during ablation in children to maximally decrease radiation dose.

Methods: Hundred sixty eight successive patients<18 years of age undergoing CA performed under a 3. Read More

View Article and Full-Text PDF

Transcatheter closure of tubular patent ductus arteriosus using muscular ventricular septal defect devices in infants and small children with congestive heart failure.

Arch Cardiovasc Dis 2022 Mar 24;115(3):134-141. Epub 2022 Feb 24.

Paediatric Cardiology Services, Royal Brompton Hospital and Harefield NHS Foundation Trust, London SW3 6NP, UK; National Heart and Lung Institute, Guy Scadding Building, London SW3 6LY, UK. Electronic address:

Background: Transcatheter closure of a patent ductus arteriosus in children is widely performed to reduce symptoms and decrease the risk of endocarditis. Most arterial ducts are closed successfully with dedicated devices. However, in a tubular or "type C" patent ductus arteriosus with congestive heart failure, the occlusion is more challenging with these devices, with a higher risk of complications, such as aortic or left pulmonary stenosis and device embolization. Read More

View Article and Full-Text PDF

Mitral valve repair is better than mitral valve replacement in native mitral valve endocarditis: Results from a prospective matched cohort.

Arch Cardiovasc Dis 2022 Mar 23;115(3):160-168. Epub 2022 Feb 23.

Cardiology Department, La Timone Hospital, AP-HM, 13005 Marseille, France; Aix-Marseille University, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, 13005 Marseille, France. Electronic address:

Background: In native mitral valve infective endocarditis (NMIE), the respective values of mitral valve repair (MVRep) and replacement (MVR) are still debated.

Aim: To compare MVRep and MVR in a large prospective matched cohort.

Methods: Between 2010 and 2017, all consecutive patients operated on for NMIE in our centre were included prospectively. Read More

View Article and Full-Text PDF

Right ventricular ejection fraction with cardiac magnetic resonance using a wall motion score.

Arch Cardiovasc Dis 2022 Mar 22;115(3):126-133. Epub 2022 Feb 22.

Division of Cardiology, Department of Medicine, Hôpital du Sacré-Cœur de Montréal, Université de Montréal, 5400 Gouin Blvd W., Montréal, QC, H4 J 1C5, Canada. Electronic address:

Background: The volumetric method in cardiac magnetic resonance (CMR), the reference standard for right ventricular ejection fraction (RVEF), requires expertise because of the complex right ventricular geometry and anatomical landmarks.

Aim: The aim of our retrospective study was to describe a new method to evaluate RVEF based on wall motion score index (WMSI) in CMR.

Methods: Visual assessment of wall motion was performed using an eight-segment model (normokinesia=1, hypokinesia=2, akinesia=3). Read More

View Article and Full-Text PDF

Timing of surgery in asymptomatic severe aortic stenosis: An unresolved issue.

Arch Cardiovasc Dis 2022 03 19;115(3):190-191. Epub 2022 Feb 19.

Department of Cardiology and Cardiovascular Surgery, clinique Saint-Augustin, 33200 Bordeaux, France.

View Article and Full-Text PDF

Septal versus apical pacing sites in permanent right ventricular pacing: The multicentre prospective SEPTAL-PM study.

Arch Cardiovasc Dis 2022 Feb 19. Epub 2022 Feb 19.

LTSI-UMR1099, université de Rennes, CHU Rennes, 35000 Rennes, France. Electronic address:

Background: The optimal right ventricular pacing site for patients requiring pacemaker implantation for permanent atrioventricular block is a matter of debate. Long-term right ventricular apical pacing has been associated with left ventricular ejection fraction impairment and heart failure. Right ventricular septal pacing has been proposed as an alternative. Read More

View Article and Full-Text PDF
February 2022

Right ventricle-pulmonary artery coupling in repaired tetralogy of Fallot with pulmonary regurgitation: Clinical implications.

Arch Cardiovasc Dis 2022 Feb 3;115(2):67-77. Epub 2022 Feb 3.

Institute of Paediatrics, Paediatric Cardiology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy; Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Background: Right ventricle-pulmonary artery (RV-PA) coupling is a strong prognostic marker in several clinical settings, but few studies have focused on its role in repaired tetralogy of Fallot (rToF) with pulmonary regurgitation.

Aim: To assess whether differences exist in RV-PA coupling, estimated by echocardiography, between patients with rToF and pulmonary regurgitation with or without an indication for pulmonary valve replacement (PVR).

Methods: The study population included 40 patients with rToF, who were allocated to two groups: 20 with an indication for PVR (i-PVR group); and 20 without an indication for PVR (ni-PVR group). Read More

View Article and Full-Text PDF
February 2022